CCTV news: a large number of consumables national and local unified collection

Medical network January 18th, like the unified collection of coronary stents or will be normal.
1, the state and local at the same time to promote the collection of consumables January 15 evening, CCTV focus interview column reported on the "crown pulse bracket after the purchase of the group" news, according to Saibai Blue equipment observation, from November 5, 2020, China's first centralized belt procurement of crown stent, to today, has passed 72 days.
the next step will continue to expand the collection, which varieties will enter the collection, which is the industry's most discussed topic.
according to CCTV news reports, in the future, will be in this time the national organization of high-value medical supplies crown stent belt procurement on the basis of the pharmaceutical supplies in the field of belt procurement will also continue.
Dong Zhaoxuan, Deputy Director of the Tendering and Procurement Department of the Price Recruitment Division of the State Administration of Medical Security, said: "In the field of pharmaceuticals, centralized belt procurement will be carried out normally, and it is expected that two batches of belt procurement will be carried out each year;
"2, the circulation field" with gold sales" has long been 10 varieties of winning bids, the price from the average price of 13,000 yuan to about 700 yuan, the crown bracket suddenly from the "ceiling price" to the "floor price", from January 1 this year, the national organization of the crown stent concentrated belt procurement results have been implemented in Beijing, Tianjin, Liaoning, Hunan and other provinces and cities after the price reduction.
that question follows, why can the price of the crown bracket be reduced so much? Will it be cheap and not good? How much benefits do patients get? Take the crown stent as an example, in 2019, the national crown stent use more than 1.6 million, the cost of more than 15 billion yuan, only one variety accounted for more than 10% of the total market value of medical supplies, and compared with the international price of similar products, the price is significantly higher.
At the same time, high-value medical supplies prices and sales methods are closely related, production enterprises to produce products, sold by agents, after layers of agents, high-value supplies factory prices and the final use of the price of the people are very different.
Chen Jinfu, deputy director of the State Health Security Administration, said: "High-value medical supplies in the field of falsely high costs, the circulation of the field of "gold sales" disease has been a long time, resulting in a high burden on the people, clinical use of drugs, including supplies is very chaotic."
based on this problem, the national decision to carry out high-value medical supplies.
"3, the winning bid is basically the mainstream products according to Saibai Blue equipment observation, in this collection procurement of a total of 11 enterprises 26 kinds of crown support to participate in this centralized procurement.
through competition, the collection of 10 products to be selected, divided into 8 domestic and foreign enterprises.
November 5, 2020, the National Health Insurance Administration gathered 80% of the national demand for chrome crown braces as the target, 1.07 million in volume exchange, centralized bidding procurement, independent quotations, low-cost winning bid.
Dong Zhaoxuan said: "The original ten largest sales of products, this time seven winning bids, and including the first place in sales, and from the enterprise point of view, the original market three largest domestic enterprises and two major multinational companies have products have won the bid, so this winning bid is basically the mainstream products."
" a medical device company said that the marketing process spent a lot of energy to make them also feel the pressure.
inflated prices can not only lead to overuse, but also to the side of some patients, as is evident in coronary stent intervention surgery.
This time the centralized belt procurement, crown bracket price from the average price of about 13,000 yuan to about 700 yuan, compared with 2019, the same enterprises of the same products reduced by an average of 93%, the average price of domestic products 92%, the average price of imported products 95%.
price reduction, whether in the future affect product quality, is also a widespread concern.
4, how to ensure quality? Volume procurement allows enterprises to save the cost of circulation links, can be more focused on production and research and development, but also let the price of crown stents significantly reduced, according to the amount of intention to purchase, the expected savings related costs of 11.7 billion yuan, and this also means that clinical treatment of patients improved access.
are naturally happy that patients are paying attention to prices and cutting prices, and before that, doctors have their concerns.
Yang Weixian, vice president of the Hospital of the Chinese Academy of Medical Sciences, said: "Don't cause some problems in product quality after the price reduction of stents, or find some problems in the use, which is our more concern."
"Because the tender is a low-cost winning bid, we are most worried about attracting some of the clinical data we have not used, clinical data in all aspects are not particularly solid, " said Du Kefei, deputy director of the Coronary Heart Disease Center at the Hospital of the Chinese Academy of Medical Sciences.
quality be regulated after the price of the "product" is reduced? "Every enterprise has submitted a commitment to ensure quality and a commitment to legal effect, " said Ding Erlei, deputy director of the price recruitment department of the State Administration of Health And Social Security.
also from the quality supervision, on the 'double eleven' day the State Drug Administration issued a special notice, all selected enterprises to carry out another round of full-coverage sampling.
"5, how much can patients save? High-quality and inexpensive coronary stents can benefit more patients, so, with the cost of coronary stents falling, a surgery down, patients pay less for surgery? Dong Zhaoxuan said: "The average cost of coronary stent implantation is 56,000 yuan, after this collection, the cost of the stent average of 1.5 stents per operation, from the original 16,000 yuan to about 1000 yuan, the overall savings of 15,000 yuan."
40% out-of-pocket for employee health insurance, one operation down, save 6000 yuan of personal payments;
" surgery is made up of health insurance payments and individual out-of-the-way payments, and while individual out-of-home costs are reduced, there are savings for the state.
Dong Zhaoxuan said: "For example, the original use of 10,000 brackets, each bracket is 10,000 yuan, now become 700 yuan a, the use of brackets because there is no overuse, the use of brackets into 9000, the original is 1 Ten thousand times 10,000 this money, is now 700 times 9000, this time there is a balance of money, then the balance of money, first of all, the patient's out-of-pocket costs reduced, the second is the money saved by health insurance, because the money to settle with the hospital less.
" experts said that we should establish a performance incentive mechanism that reflects the value of medical personnel, and further mobilize the enthusiasm of medical personnel.
we have an incentive mechanism, which is to retain the balance, " said Dong Zhaoxuan, a professor at the Hong Kong Government.
the balance of medical insurance and hospital settlement, some of the money left to medical institutions after examination, encourage medical institutions to establish an internal assessment mechanism, the balance of the money retained as a doctor's salary and benefits to medical personnel.
hope that this reform will be truly supported by medical personnel, so that medical personnel become practitioners of the reform.
”